Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human CCR5 ELISA Kit (AC3801)
Cat.#: ASET-2390
Specifications
Description Human CCR5 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human CCR5 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 2.61 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 75-1200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2022 Human NOTCH3 ELISA Kit (AC3433) Quantitative inquiry ASET-1525 Human beta Catenin ELISA Kit (AC2936) Quantitative inquiry ASET-1662 Rat TIMP1 ELISA Kit (AC3073) Quantitative inquiry ASET-1308 Human Eph Receptor A2 ELISA Kit (AC2719) Quantitative inquiry ASET-2198 Human Metabotropic Glutamate Receptor 5 ELISA Kit (AC3609) Quantitative inquiry ASET-2130 Rat Adenosine Receptor A2a ELISA Kit (AC3541) Quantitative inquiry ASET-1598 Human Syntenin ELISA Kit (AC3009) Quantitative inquiry ASET-1843 Human CRCP ELISA Kit (AC3254) Quantitative inquiry ASET-1328 Human ZFYVE27 ELISA Kit (AC2739) Quantitative inquiry ASET-1857 Human DLL1 ELISA Kit (AC3268) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket